Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorNanjing First Hospital, Nanjing Medical University
About this trial
This study aimed to characterize the progression and risk fators of coronary artery aneurysms, and copmpare the outcomes across different management strategies
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Angiographically confirmed coronary artery aneurysm, defined as coronary dilation ≥1.5 times the adjacent normal reference vessel diameter.
Age 18-80 years.
Disqualifiers
Suboptimal image quality
Incomplete clinical data, including medical history, laboratory parameters, or follow-up records.
Trial population
patients diagnosed with coronary artery aneurysm
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupGroup A: Coronary Artery Aneurysms
Trial outcomes
Primary outcomes
1
Progression of coronary artery aneurysm
Progression of coronary artery aneurysm assessed by serial angiography or coronary computed tomography angiography
Time frame
6-12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov